StephenPKahanicMD

Oncology • Sioux City, IA

Physician

Join to view full profile

Dr. Kahanic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kahanic's full profile

Already have an account?

Office
230 Nebraska St
Sioux City, IA 51101
Phone+1 712-252-0088

Fax+1 712-252-5271
Is this information wrong?

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1989 - 1992
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1986 - 1989
Case Western Reserve University School of MedicineClass of 1986

Certifications & Licensure

IA State Medical License 1989 - 2024
NE State Medical License 1993 - 2018
American Board of Internal Medicine Internal Medicine

Clinical Trials

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study Start of enrollment: 2010 Mar 22
Completed
Phase 2

Publications & Presentations

PubMed

88 citations
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) wit...
Brian G.M. Durie, Antje Hoering, Rachael Sexton, Muneer H. Abidi, Joshua Epstein, S. Vincent Rajkumar, Angela Dispenzieri, Stephen P. Kahanic, Mohan C. Thakuri, Freder...> ;Blood Cancer Journal. 2020 May 11
571 citations
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autolo...
Brian G.M. Durie, Antje Hoering, Muneer H. Abidi, S. Vincent Rajkumar, Joshua Epstein, Stephen P. Kahanic, Mohan C. Thakuri, Frederic J. Reu, Christopher M. Reynolds, ...> ;Lancet. 2017 Feb 4
29 citations
Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198)
Bryan P. Schneider, Anne O'Neill, Fei Shen, George W. Sledge, Ann D. Thor, Stephen P. Kahanic, Paul J. Zander, Nancy E. Davidson> ;British Journal of Cancer. 2015 Dec 22
27 citations
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma.
Myron S. Czuczman, Stephen Kahanic, Andres Forero, Glen L. Davis, Mihaela C. Munteanu, Eric Van Den Neste, Fritz Offner, Dominique Bron, Donald Quick, Nathan Fowler> ;Annals of Hematology. 2015 Jan 30
14 citations
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer
Alvaro Moreno-Aspitia, Amylou C. Dueck, Ismael Ghanem-Cañete, Tejal Patel, Shaker R. Dakhil, David B. Johnson, Sandra X. Franco, S. P. Kahanic, Gerardo Colon-Otero, Ka...> ;Breast Cancer Research and Treatment. 2013 Mar 12
77 citations
Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients Wi...
David P. Steensma, Jeff A. Sloan, Shaker R. Dakhil, Robert J. Dalton, S. P. Kahanic, Diane Prager, Philip J. Stella, Kendrith M. Rowland, Paul J. Novotny, Charles L. L...> ;Journal of Clinical Oncology. 2011 Jan 1
65 citations
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC.
Stephanie L. Hines, Betty A. Mincey, Todor Dentchev, Jeff A. Sloan, Edith A. Perez, David B. Johnson, Paul L. Schaefer, Steve R. Alberts, Heshan Liu, S. P. Kahanic, Mi...> ;Breast Cancer Research and Treatment. 2009 Feb 12
123 citations
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment G...
Aminah Jatoi, Kendrith M. Rowland, Jeff A. Sloan, Howard M. Gross, Paul A. S. Fishkin, S. P. Kahanic, Paul J. Novotny, Paul L. Schaefer, David B. Johnson, Loren K. Tsc...> ;Cancer. 2008 Aug 15
N03CC-a randomized, controlled, open-label trial of upfront vs. delayed zoledronic acid for prevention of bone loss in postmenopausal (PM) women with primary breast ca...
Mincey BA, Dentchev T, Sloan JA, Hines SL, Perez EA, Johnson DB, Schaefer PL, Liu H, Kahanic SP, Loprinzi CL> ;J. Clin. Oncol.. 2008-05-20
A phase I/II NCCTG trial of escalating doses of twice daily thoracic radiation therapy (TRT) in limited-stage small cell lung cancer (LSCLC).
Garces YI, Okuno SH, Schild SE, Mandrekar SJ, Mailliard JA, Kahanic SP, Rao RM, Moore DF, Kozelsky TF, Jett JR> ;J. Clin. Oncol.. 2005-06-01
25 citations
Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs.
Aminah Jatoi, S. P. Kahanic, Stephen Frytak, Paul L. Schaefer, Robert L. Foote, Jeff A. Sloan, Ronald C. Petersen> ;Supportive Care in Cancer. 2005 Jan 1
NCCTG trial of gemcitabine for relapsed B-cell chronic lymphocytic leukemia.
Call TG, Constantinou CL, Kahanic SP, Rowland KM, Dakil SR, Hoering A, Li CY, Dewald GW, Kay NE, Witzig TE> ;J. Clin. Oncol.. 2004-07-15
Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis.
McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR, Shanahan TG, Kahanic SP, Moore RL, Schild SE, Humphrey SL> ;J. Clin. Oncol.. 1997-03-01
Join now to see all

Lectures

Longer Term Follow up of the Â Randomized Phase III Trial SWOG S0777: Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) w...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018